Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
2(17%)
Results Posted
56%(5 trials)

Phase Distribution

Ph early_phase_1
1
8%
Ph not_applicable
2
17%
Ph phase_4
4
33%
Ph phase_2
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
4(50.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(9)

Detailed Status

Completed9
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 44 (50.0%)
N/A2 (25.0%)

Trials by Status

completed975%
recruiting217%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12